Alvimopan (monohydrate)


CAS No. : 1383577-62-5

(Synonyms: ADL 8-2698 monohydrate; LY 246736 monohydrate)

1383577-62-5
Price and Availability of CAS No. : 1383577-62-5
Size Price Stock
2mg $80 In-stock
5 mg Get quote
10 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-76657
M.Wt: 442.55
Formula: C25H34N2O5
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1383577-62-5 :

Alvimopan monohydrate (ADL 8-2698 monohydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan monohydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan monohydrate can be used for the research of postoperative ileus[1][2][3]. IC50 & Target:IC50: 1.7 nM (μ-opioid receptor)[1] In Vitro:Alvimopan inhibits the loperamide-stimulated [35S]GTPγS binding to membranes containing the cloned human μ-opioid receptor, with an IC50 of 1.7 nM[1]. In Vivo:Alvimopan (0.1-1.0 mg/kg; p.o.) partially antagonizes the slowing of small intestinal transit of 113Sn-labelled microspheres in rats[3].
Alvimopan (3 mg/kg; p.o.) has no effect on the visceromotor behavioural responses (VMR) induced by noxious colorectal distension (CRD) in conscious rats[3].

Your information is safe with us.